Navigation Links
Expert in IVD Software joins Visiopharm’s Board of Directors
Date:1/3/2013

Hørsholm, Denmark (PRWEB) January 03, 2013

Visiopharm a leader of Quantitative Digital Pathology solutions announced today that Dr. Henrik Stender will join Visiopharm’s Board of Directors.

Dr. Henrik Stender is co-founder of AdvanDx, where he was the Vice President of Research & Development. While with AdvanDx, he spearheaded the development of their PNA FISH technology; including clinical and regulatory activities for in-vitro diagnostic (IVD) use in Europe and in the United States. Today, as owner of Stender Diagnostics, Dr. Stender uses an ’IVD Factory’ concept to streamline the development process towards high quality products in compliance with quality system requirements (QSR) for regulatory approvals. Prior to AdvanDx, Henrik was at Applied Biosystems, Boston Probes, and Dako, where he built a deep and broad knowledge about medical devices and in-vitro diagnostics.

“I am very excited about joining Visiopharm, and see tremendous potential for their diagnostic solutions. Visiopharm already has a strong portfolio of algorithms for nuclear, membrane, and gene-probe analysis, which is currently under clinical validation and subsequent deployment at several hospitals. Still, there is a strong focus on developing and validating novel technology in software modules that truly addresses the demand for doing things better, faster, and cheaper. I believe this will be part of defining the future of Digital Pathology”, says Dr. Henrik Stender.

Michael Grunkin, CEO at Visiopharm stated “In-vitro diagnostics is a key business area for Visiopharm. We have an exciting development pipeline of IVD algorithms for the breast tumor panel, and this will set the foundation for the development of several other tumor panels. Dr. Stender is an important addition to our Board of Directors. His extensive knowledge and experience in the development of IVD products will be a great contribution to Visiopharm."

Johan Doré, CTO at Visiopharm adds, “We are seeing some interesting changes in Scandinavia these years, when it comes to adoption of Digital Pathology. We are collaborating with several hospitals in moving Digital Pathology into the clinic, and we have a very strong clinical network for validation though our close collaboration with the NordiQC. With his experience, Henrik is helping us optimizing our development work and clinical network in a regulatory context.”

Visiopharm recently introduced the HER2-CONNECT algorithm as their first CE-IVD cleared module and they are scheduled to launch a full CE-IVD tumor panel in 2013.

About Visiopharm

Over the past 10 years, Visiopharm image analysis and stereology software has become the preferred Quantitative Digital Pathology solution for leading biopharmaceutical companies, clinical researchers, and academic researchers all over the world. Visiopharm has more than 350 deployed systems worldwide and a large network of distribution and support partners, and is featured in over 400 scientific publications.

Read the full story at http://www.prweb.com/releases/2013/IVDExpert/prweb10277348.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Nutrisystem Announces Latest Weight Loss Success Story: Long Beach Husband and Wife Drop a Combined Total of 46 Pounds; Plus, Expert Dieting Tips for Couples
2. Kettlebell Expert Lorna Kleidman Responds to the Rise in Fitness Parks throughout Major Cities
3. Fitness Expert Lorna Kleidman Comments on Article Concerning Weight Loss as a New Year’s Resolution
4. Whats Best for Kids Eye Health? Experts Give Insight
5. Boughs of Christmas Trees Hold Many Insects, Bug Expert Says
6. Its OK for Kids to Keep Believing in Santa, Expert Says
7. Stakeholder Communities in China and Korea – by Heartbeat Experts
8. Grief Expert Says "We Don't Die" and Offers Free Aid to Mourners
9. Aspergers, Autism Not Linked to Violence: Experts
10. Banning Vaccine Preservative Would Hurt Kids in Poor Nations: Experts
11. GLOBODOX (Enterprise Document Management Software) Launches Contest for Legal Experts to Define Technology Challenges Expected in 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet’s ... ostomy patients, standing as living proof that attitude and determination can combine into ... issues that spike around the holidays. This campaign will offer patients a new-found ...
(Date:12/2/2016)... Hawaii (PRWEB) , ... December 02, 2016 , ... ... 2016 at the Hyatt Regency Waikiki Beach Resort and Spa in Honolulu, offering ... in the field of pain management. , The demand for supplemental training ...
(Date:12/2/2016)... Viejo, California (PRWEB) , ... December 02, 2016 , ... ... will allow FCPX editors to create versatile lower third titles with just a few ... , Pro3rd Accents Volume 2 includes 30 lower third animations. Choose from various styles ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ‘Tis the season ... of $1,000 each from the National Family Partnership and the Drug Enforcement Administration as ... decorated their homes and the 10 winning schools who decorated their campuses with this ...
(Date:11/30/2016)... ... November 30, 2016 , ... Center For ... announced the opening of a new eating disorder treatment center location in Palm ... for adults and adolescents, both males and females ages 10 and older with ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2, 2016 In the first ever attempt ... those derived from C. sativa, the Hebrew University in ... Napoli Federico II , the Universita` del Piemonte Orientale ... critical, integrated and unified inventory of phytocannabinoids of different ... on the remarkable chemical and structural diversity of phytocannabinoids. ...
(Date:12/2/2016)... Columbia , December 2, 2016 bioLytical Laboratories, ... INSTI HIV-Selbsttest, bei den Mitgliedern des Apothekenbundes von Kenia eingeführt. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ...
(Date:12/2/2016)... 2016   CytoSorbents Corporation (NASDAQ: CTSO ... Union approved CytoSorb ® cytokine adsorber to treat ... announced that Dr. Phillip Chan , Chief Executive ... Micro Main Event investor conference held from December ... Sunset Boulevard Hotel in Los Angeles, California ...
Breaking Medicine Technology: